
AI for Biotech: A Build vs. Buy Decision Framework
A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, and vendor evaluation criteria.

A framework for biotech CDOs on the build vs. buy AI decision. Analyzes costs, time-to-value, integration challenges, and vendor evaluation criteria.

Examines Kimi K2, a trillion-parameter open-weight LLM from Moonshot AI. Learn its technical details, development background, and strategic context.

This guide details a structured approach for Generative AI adoption in life sciences, covering strategy, governance, technology, training, and ethical considerations.